(Q41127745)

27 September 2017

title

Detection and quantification of cyclosporine in body fluids using an interleukin-2 reporter-gene assay (English)

1 reference

27 September 2017

1 reference

Wenner PR

1

1 reference

27 September 2017

Di Padova F

series ordinal

2

1 reference

27 September 2017

Keown PA

series ordinal

3

1 reference

27 September 2017

language of work or name

1 reference

1 February 1997

1 reference

Journal of Immunological Methods

27 September 2017

published in

1 reference

27 September 2017

volume

201

1 reference

27 September 2017

issue

1

1 reference

27 September 2017

page(s)

125-135

1 reference

The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE)

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

Biological effects of cyclosporin A: A new antilymphocytic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

The optimal use of cyclosporin A in autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

Cyclosporin monitoring: its role in autoimmune indications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

Monoclonal antibodies to cyclosporin are representative of the major antibody populations present in antisera of immunized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

Human cyclophilin C: primary structure, tissue distribution, and determination of binding specificity for cyclosporins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

The mechanism of action of cyclosporin A and FK506

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

Inter- and intra-subject variation of the suppression of mitogen-induced proliferation of human lymphocytes by cyclosporin-A: reduction of response with delayed addition may be relevant to timing of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

Cyclosporine: structure, pharmacokinetics, and therapeutic drug monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

Molecular mechanisms of immunosuppression by cyclosporins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900219-0

10.1016/S0022-1759(96)00219-0

7 January 2021

Identifiers

DOI

1 reference

27 September 2017

1 reference